Cardiovascular Device Update articles from May 2005

Cardiovascular Device Update archives from May 2005

Expanding applications seen for a wider variety of technology.(American College of Cardiolog meetings)
May 1, 2005... Expanding applications seen for a wider variety of technology By MICHAEL SIMONSEN, PhD CDU Contributing Editor ORLAND, Florida - The 2005 scientific sessions of the American College of Cardiology (ACC, Bethesda, Maryland), held...

Economic and political trends impact medical technology industry.
May 1, 2005... Economic and political trends impact medical technology industry By MICHAEL SIMONSEN, PhD CDU Contributing Editor IRVINE, California - The U.S. medical device industry, which generated more than $80 billion in sales in 2004 and is...

Growth of med-tech sector is a boon to Ireland's economy.
May 1, 2005... Growth of med-tech sector is a boon to Ireland's economy By JIM STOMMEN CDU Executive Editor Irish eyes are smiling - on the medical technology sector. Or maybe they're smiling because of the med-tech sector. With more than...

Life after DES: The search for the next blockbuster product.(drug-eluting stents)
May 1, 2005... Life after DES: The search for the next blockbuster product By CHRISTOPHER DELPORTE CDU Washington Editor WASHINGTON - As they enter the market, most new medical devices owe their possible success to a convergence of different...

International report.(Rubicon Medical recieves approval for Rubicon Filter)(Eucomed welcomes European research guidelines)(ThermoGenesis gets pre-market approval for Japan)
May 1, 2005... International report Rubicon Medical gets nod for Rubicon Filter A CDU Staff Report Rubicon Medical (Salt Lake City) said in mid-April that it had received the CE mark for its Rubicon Filter, an embolic protection system that...

Acquisitions.(Boston Scientific acquires TriVascular)(Hansen Medical purchases intellectual property from endoVia Medical)(Pediatrix Medical Group acquires Miami-based pediatric cardiology practice)
May 1, 2005... Acquisitions * Boston Scientific (Natick, Massachusetts) said it has acquired TriVascular (Santa Rosa, California), a privately held company that develops less-invasive medical devices and medical procedures for treating abdominal aortic...

Business Developments.
May 1, 2005... Business Developments Arrow discontinues its LionHeart LVAS effort After nearly a decade of development and millions of dollars invested, Arrow International (Reading, Pennsylvania), after nearly a decade of development and millions...

Agreements.(AMI Semiconductor partnership with Interventional Rhythm Management)(Delphi Medical Systems licensing agreement with Inovise Medical)(GE Healthcare contract from HealthTrust Purchasing Group)
May 1, 2005... Agreements * AMI Semiconductor (Pocatello, Idaho), a manufacturer of integrated mixed-signal and structured digital products, has formed a technology design and supply partnership with Interventional Rhythm Management (IRM; Research...

Market Updates.(Boston Scientific and Cordis unit of Johnson & Johnson fighting for market share)(Agency for Healthcare Research and Quality announces quality initiative)(chronic kidney disease and heart disease risk)
May 1, 2005... Market Updates Boston Sci maintains lead in DES sector Boston Scientific (Natick, Massachusetts) and the Cordis unit (Miami Lakes, Florida) of Johnson & Johnson (J&J; New Brunswick, New Jersey) continued their marketing slugfest in the...

Personnel File.(Heart Rhythm Society)(Brief Article)
May 1, 2005... Personnel File * Anne Curtis, MD, will be named president of the Heart Rhythm Society (Washington) during Heart Rhythm 2005, the society's 26th annual scientific sessions, this month in New Orleans. Curtis, director of cardiology and CEO...

Product Pipeline.(ACI Medical reports postive results for ArtAssist device)(Alliance Medical gets partial approval on catheters)(Abbott Vascular neck artery stent trial)
May 1, 2005... Product Pipeline 1st patient enrolled in Abbott ACT I trial Reflecting the company's new emphasis on the interventional sector, Abbott Laboratories' (Abbott Park, Illinois) last month reported two major forward steps in the product...